BTEE - iShares Nasdaq US Biotechnology UCITS ETF USD (Dist), IE00BDZVHG35 | Cbonds
ヒントモードがオンになっています オフ

BTEE - iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (IE00BDZVHG35)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
IE00BDZVHG35
BTEE ISIN
上場投資信託(ETF)
ファンドのタイプ
BlackRock
プロバイダー
9.48 USD
一口当たり純資産価値(NAV) | 2026/07/21
2018/03/05
設定日
2 年回
配当支払い
CEOIES
CFI
BTEE
ティッカー
Formed
ステータス
Equity
投資カテゴリー
Biotech
セクター
USA
投資家所在地
Nasdaq Biotechnology Index(R)
ベンチマーク
0.35 %
総保有コスト率(Total Cost Ratio)
1,161.95 百万 USD
ファンド基準価額 | 2026/07/21
73.85 百万 USD
株式クラス純資産価値(Share Class NAV) | 2026/07/21
はい
UCITS

最新データ
比較する要素を追加

相場(BTEE)

最も包括的なデータベースを探索

1 000 000

債券

100 000

175 910

ETF&投資信託

100 000

インデックス

最も効率的な方法でポートフォリオを追跡

  • 債券検索
  • ウォッチリスト
  • Excelアドイン

価格推移

ファンドプロファイル

The iShares Nasdaq US Biotechnology UCITS ETF seeks to replicate as close as possible the price and yield performance of the NASDAQ Biotechnology Index by investing in a portfolio comprised primarily of biotechnology and pharmaceutical equities listed on the NASDAQ

BTEE プロファイル

The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Biotech sector located in USA. The BlackRock fund’s base currency is USD and the share class was registered 05.03.2018 with unique ISIN - IE00BDZVHG35. Main exchange is London S.E. (USD) and ticker symbol is BTEE. The total expense ratio is 0.35%. The iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) pays dividends 2 time(s) per year.

構造 BTEE 時点 2026/07/20

証券 価値
AMGEN INC 8.11%
VERTEX PHARMACEUTICALS INC 8.05%
GILEAD SCIENCES INC 7.43%
REGENERON PHARMACEUTICALS INC 4.95%
REVOLUTION MEDICINES INC 2.74%
ALNYLAM PHARMACEUTICALS INC 2.6%
BIOGEN INC 2.11%
ILLUMINA INC 2.%
ROYALTY PHARMA PLC CLASS A 1.82%
ROIVANT SCIENCES LTD 1.75%
MODERNA INC 1.69%
ARGENX SE ADR 1.67%
INSMED INC 1.66%
INCYTE CORP 1.65%
UNITED THERAPEUTICS CORP 1.61%
VIATRIS INC 1.42%
GUARDANT HEALTH INC 1.4%
NEUROCRINE BIOSCIENCES INC 1.24%
BRIDGEBIO PHARMA INC 1.13%
ASCENDIS PHARMA 1.11%
JAZZ PHARMACEUTICALS PLC 1.09%
MEDPACE HOLDINGS INC 1.08%
EXELIXIS INC 1.%
MADRIGAL PHARMACEUTICALS INC 0.88%
AXSOME THERAPEUTICS INC 0.82%
BIOMARIN PHARMACEUTICAL INC 0.81%
CYTOKINETICS INC 0.76%
BIONTECH SE ADR 0.76%
SUMMIT THERAPEUTICS INC 0.75%
BEONE MEDICINES AG 0.73%
SANOFI ADR REPRESENTING SA 0.73%
ARROWHEAD PHARMACEUTICALS INC 0.72%
KRYSTAL BIOTECH INC 0.71%
HALOZYME THERAPEUTICS INC 0.65%
KYMERA THERAPEUTICS INC 0.65%
CRINETICS PHARMACEUTICALS INC 0.63%
IONIS PHARMACEUTICALS INC 0.63%
PROTAGONIST THERAPEUTICS INC 0.62%
ALKERMES 0.62%
PRAXIS PRECISION MEDICINES INC 0.61%
SPYRE THERAPEUTICS INC 0.6%
TEMPUS AI INC CLASS A 0.6%
APOGEE THERAPEUTICS INC 0.59%
IMMUNOVANT INC 0.59%
VAXCYTE INC 0.57%
IMMUNITYBIO INC 0.56%
ABIVAX AMERICAN DEPOSITARY SHARES 0.55%
RHYTHM PHARMACEUTICALS INC 0.51%
MIRUM PHARMACEUTICALS INC 0.51%
COGENT BIOSCIENCES INC 0.47%
PTC THERAPEUTICS INC 0.46%
XENON PHARMACEUTICALS INC 0.46%
CG ONCOLOGY INC 0.44%
SCHOLAR ROCK HOLDING CORP 0.43%
LIGAND PHARMACEUTICALS INC 0.42%
ERASCA INC 0.42%
AMNEAL PHARMACEUTICALS INC CLASS A 0.4%
ORUKA THERAPEUTICS INC 0.4%
TWIST BIOSCIENCE CORP 0.39%
TRAVERE THERAPEUTICS INC 0.37%
10X GENOMICS INC CLASS A 0.36%
INDIVIOR PHARMACEUTICALS INC 0.34%
DEFINIUM THERAPEUTICS INC 0.34%
VERACYTE INC 0.33%
CRISPR THERAPEUTICS AG 0.33%
CARIS LIFE SCIENCES INC 0.32%
ACADIA PHARMACEUTICALS INC 0.31%
EDGEWISE THERAPEUTICS INC 0.3%
RELAY THERAPEUTICS INC 0.3%
TANGO THERAPEUTICS INC 0.29%
DYNE THERAPEUTICS INC 0.28%
STRUCTURE THERAPEUTICS ADR INC 0.26%
DENALI THERAPEUTICS INC 0.26%
ADAPTIVE BIOTECHNOLOGIES CORP 0.25%
NEWAMSTERDAM PHARMA NV 0.25%
ALUMIS INC 0.24%
ARCUTIS BIOTHERAPEUTICS INC 0.24%
ENLIVEN THERAPEUTICS INC 0.23%
IDEAYA BIOSCIENCES INC 0.22%
GRAIL INC 0.21%
KINIKSA PHARMACEUTICALS INTERNATIO 0.21%
MBX BIOSCIENCES INC 0.2%
DISC MEDICINE INC 0.2%
ULTRAGENYX PHARMACEUTICAL INC 0.2%
SUPERNUS PHARMACEUTICALS INC 0.19%
BEAM THERAPEUTICS INC 0.19%
ATAIBECKLEY INC 0.19%
VERA THERAPEUTICS INC CLASS A 0.19%
KODIAK SCIENCES INC 0.19%
UNIQURE NV 0.18%
TARSUS PHARMACEUTICALS INC 0.17%
AGIOS PHARMACEUTICALS INC 0.17%
NURIX THERAPEUTICS INC 0.17%
VERICEL CORP 0.17%
TREVI THERAPEUTICS INC 0.17%
BIOCRYST PHARMACEUTICALS INC 0.17%
PHARVARIS N V NV 0.17%
USD CASH 0.16%
IOVANCE BIOTHERAPEUTICS INC 0.16%
MINERALYS THERAPEUTICS INC 0.16%
その他 - %

このプロバイダーのその他のETF&ファンド

類似のETF&ファンド

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} 百万
    純資産価値(NAV)
    {{ item.expense_ratio }}
    総経費率(TER)
登録 is required アクセスを得るために必要です。